4-hydroxy-2-nonenal and Stomatitis--Aphthous

4-hydroxy-2-nonenal has been researched along with Stomatitis--Aphthous* in 1 studies

Other Studies

1 other study(ies) available for 4-hydroxy-2-nonenal and Stomatitis--Aphthous

ArticleYear
Increased beta 2 defensin in recurrent aphthous ulcer.
    Oral diseases, 2015, Volume: 21, Issue:3

    It was hypothesized that beta 2 defensin (BD-2) is increased in RAU lesions compared with healthy controls to promote anti-microbial host defence.. RAU and control mucosa samples were subjected to quantitative real-time PCR and immunostained for BD-2, CD68, mast cell tryptase and 4-hydroxynonenal (4HNE). The effect of tumour necrosis factor-α (TNF-α) ± interleukin-17C (IL-17C), without and with vitamin K3, was studied on BD-2 expression in epithelial SCC-25 cells.. Although BD-2 mRNA did not differ between healthy and RAU mucosa, BD-2 stained strongly in acute-phase RAU epithelium (P = 0.001). In controls, subepithelial BD-2(+) cells were mast cells and macrophages, whereas in RAU, most infiltrating leucocytes were BD-2(+) (P = 0.004). In cell culture, BD-2 was increased 124-fold by TNF-α (P < 0.0001) and 208-fold synergistically together with IL-17C (P < 0.0001). 4HNE staining of RAU epithelium was not significantly increased, and vitamin K3-induced reactive oxygen species (ROS) did not affect BD-2.. Anti-microbial BD-2 was not affected by oxidative stress but was highly increased in the epithelial and immigrant cells in the acute-phase RAU lesions, probably in part synergistically by TNF-α and epithelial IL-17C, which are known to be induced by activation of danger-signal receptors by pathogen- and/or damage-associated molecular patterns.

    Topics: Adult; Aldehydes; beta-Defensins; Case-Control Studies; Cell Line; Female; Gene Expression; Humans; Interleukin-17; Male; Middle Aged; Mouth Mucosa; Oxidative Stress; RNA, Messenger; Stomatitis, Aphthous; Tumor Necrosis Factor-alpha; Young Adult

2015